Infectious complications following nonmyeloablative allogeneic hematopoietic stem cell transplantation

Alessandro Busca, F. Locatelli, A. Barbui, V. Ghisetti, D. Cirillo, R. Serra, E. Audisio, M. Falda

Research output: Contribution to journalArticle

Abstract

Nonmyeloablative hematopoietic stem cell transplantation (NST) has been explored in hematological malignancies and solid tumors in an attempt to minimize treatment-related toxicity. Whether this approach is associated with reduced risk of infectious complications is unclear. The aim of the current study was to evaluate the infectious complications in a series of 32 consecutive adult patients who received NSTat our institution. Peripheral blood stem cell grafts (n = 30) or marrow grafts (n = 2) were infused from human leukocyte antibody (HLA)·matched sibling (n = 30), partially matched related (n = 1), or unrelated (n = 1) donors. Neutropenia developed in two-thirds of patients and lasted 16 days. Acute graft-versus-host disease (GVHD) grade II to IV was observed in 25% of patients, whereas 35% of patients had signs of extensive chronic GVHD. Twenty-two patients (69%) had at least one significant infectious episode. Bacteremia occurred in 19% of patients (n = 5 gram-positive, n = 1 gram-negative microorganisms). Cytomegalovirus (CMV) infection was observed in 10 out of 28 (36%) evaluable patients; 4 of these had recurrent or persistent CMVantigenemia requiring a second-line treatment, but eventually the viremia cleared. No patients experienced CMV disease. Fungal infections were documented in five (16%) patients, comprising invasive fungal infections in two cases and mucosal fungal infections in three. Four patients died of transplant-related causes, and three of these died before day + 100. Infection was considered the primary cause of death in one patient (pulmonary aspergillosis) and contributed to death in another two. The actuarial probability of nonrelapse mortality at 100 days was 10% (95% confidence interval, 3-26%). Our preliminary results suggest that NST is associated to a low incidence of bacteremia or fungal and viral infections. Whether these findings would translate into an improved overall survival needs to be confirmed in larger prospective studies.

Original languageEnglish
Pages (from-to)132-139
Number of pages8
JournalTransplant Infectious Disease
Volume5
Issue number3
DOIs
Publication statusPublished - Sep 2003

Fingerprint

Hematopoietic Stem Cell Transplantation
Mycoses
Graft vs Host Disease
Bacteremia
Transplants
Pulmonary Aspergillosis
Viremia
Cytomegalovirus Infections
Virus Diseases
Hematologic Neoplasms
Neutropenia
Cytomegalovirus
Siblings
Cause of Death
Leukocytes
Bone Marrow
Tissue Donors
Prospective Studies
Confidence Intervals

Keywords

  • Bacteremia
  • Fungal infections
  • Hematopoietic stem cell transplantation
  • Infectious complications
  • Viral infections

ASJC Scopus subject areas

  • Transplantation
  • Microbiology (medical)
  • Immunology

Cite this

Infectious complications following nonmyeloablative allogeneic hematopoietic stem cell transplantation. / Busca, Alessandro; Locatelli, F.; Barbui, A.; Ghisetti, V.; Cirillo, D.; Serra, R.; Audisio, E.; Falda, M.

In: Transplant Infectious Disease, Vol. 5, No. 3, 09.2003, p. 132-139.

Research output: Contribution to journalArticle

Busca, Alessandro ; Locatelli, F. ; Barbui, A. ; Ghisetti, V. ; Cirillo, D. ; Serra, R. ; Audisio, E. ; Falda, M. / Infectious complications following nonmyeloablative allogeneic hematopoietic stem cell transplantation. In: Transplant Infectious Disease. 2003 ; Vol. 5, No. 3. pp. 132-139.
@article{ee9d1af7ac604136ac57110352067793,
title = "Infectious complications following nonmyeloablative allogeneic hematopoietic stem cell transplantation",
abstract = "Nonmyeloablative hematopoietic stem cell transplantation (NST) has been explored in hematological malignancies and solid tumors in an attempt to minimize treatment-related toxicity. Whether this approach is associated with reduced risk of infectious complications is unclear. The aim of the current study was to evaluate the infectious complications in a series of 32 consecutive adult patients who received NSTat our institution. Peripheral blood stem cell grafts (n = 30) or marrow grafts (n = 2) were infused from human leukocyte antibody (HLA)·matched sibling (n = 30), partially matched related (n = 1), or unrelated (n = 1) donors. Neutropenia developed in two-thirds of patients and lasted 16 days. Acute graft-versus-host disease (GVHD) grade II to IV was observed in 25{\%} of patients, whereas 35{\%} of patients had signs of extensive chronic GVHD. Twenty-two patients (69{\%}) had at least one significant infectious episode. Bacteremia occurred in 19{\%} of patients (n = 5 gram-positive, n = 1 gram-negative microorganisms). Cytomegalovirus (CMV) infection was observed in 10 out of 28 (36{\%}) evaluable patients; 4 of these had recurrent or persistent CMVantigenemia requiring a second-line treatment, but eventually the viremia cleared. No patients experienced CMV disease. Fungal infections were documented in five (16{\%}) patients, comprising invasive fungal infections in two cases and mucosal fungal infections in three. Four patients died of transplant-related causes, and three of these died before day + 100. Infection was considered the primary cause of death in one patient (pulmonary aspergillosis) and contributed to death in another two. The actuarial probability of nonrelapse mortality at 100 days was 10{\%} (95{\%} confidence interval, 3-26{\%}). Our preliminary results suggest that NST is associated to a low incidence of bacteremia or fungal and viral infections. Whether these findings would translate into an improved overall survival needs to be confirmed in larger prospective studies.",
keywords = "Bacteremia, Fungal infections, Hematopoietic stem cell transplantation, Infectious complications, Viral infections",
author = "Alessandro Busca and F. Locatelli and A. Barbui and V. Ghisetti and D. Cirillo and R. Serra and E. Audisio and M. Falda",
year = "2003",
month = "9",
doi = "10.1034/j.1399-3062.2003.00027.x",
language = "English",
volume = "5",
pages = "132--139",
journal = "Transplant Infectious Disease",
issn = "1398-2273",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Infectious complications following nonmyeloablative allogeneic hematopoietic stem cell transplantation

AU - Busca, Alessandro

AU - Locatelli, F.

AU - Barbui, A.

AU - Ghisetti, V.

AU - Cirillo, D.

AU - Serra, R.

AU - Audisio, E.

AU - Falda, M.

PY - 2003/9

Y1 - 2003/9

N2 - Nonmyeloablative hematopoietic stem cell transplantation (NST) has been explored in hematological malignancies and solid tumors in an attempt to minimize treatment-related toxicity. Whether this approach is associated with reduced risk of infectious complications is unclear. The aim of the current study was to evaluate the infectious complications in a series of 32 consecutive adult patients who received NSTat our institution. Peripheral blood stem cell grafts (n = 30) or marrow grafts (n = 2) were infused from human leukocyte antibody (HLA)·matched sibling (n = 30), partially matched related (n = 1), or unrelated (n = 1) donors. Neutropenia developed in two-thirds of patients and lasted 16 days. Acute graft-versus-host disease (GVHD) grade II to IV was observed in 25% of patients, whereas 35% of patients had signs of extensive chronic GVHD. Twenty-two patients (69%) had at least one significant infectious episode. Bacteremia occurred in 19% of patients (n = 5 gram-positive, n = 1 gram-negative microorganisms). Cytomegalovirus (CMV) infection was observed in 10 out of 28 (36%) evaluable patients; 4 of these had recurrent or persistent CMVantigenemia requiring a second-line treatment, but eventually the viremia cleared. No patients experienced CMV disease. Fungal infections were documented in five (16%) patients, comprising invasive fungal infections in two cases and mucosal fungal infections in three. Four patients died of transplant-related causes, and three of these died before day + 100. Infection was considered the primary cause of death in one patient (pulmonary aspergillosis) and contributed to death in another two. The actuarial probability of nonrelapse mortality at 100 days was 10% (95% confidence interval, 3-26%). Our preliminary results suggest that NST is associated to a low incidence of bacteremia or fungal and viral infections. Whether these findings would translate into an improved overall survival needs to be confirmed in larger prospective studies.

AB - Nonmyeloablative hematopoietic stem cell transplantation (NST) has been explored in hematological malignancies and solid tumors in an attempt to minimize treatment-related toxicity. Whether this approach is associated with reduced risk of infectious complications is unclear. The aim of the current study was to evaluate the infectious complications in a series of 32 consecutive adult patients who received NSTat our institution. Peripheral blood stem cell grafts (n = 30) or marrow grafts (n = 2) were infused from human leukocyte antibody (HLA)·matched sibling (n = 30), partially matched related (n = 1), or unrelated (n = 1) donors. Neutropenia developed in two-thirds of patients and lasted 16 days. Acute graft-versus-host disease (GVHD) grade II to IV was observed in 25% of patients, whereas 35% of patients had signs of extensive chronic GVHD. Twenty-two patients (69%) had at least one significant infectious episode. Bacteremia occurred in 19% of patients (n = 5 gram-positive, n = 1 gram-negative microorganisms). Cytomegalovirus (CMV) infection was observed in 10 out of 28 (36%) evaluable patients; 4 of these had recurrent or persistent CMVantigenemia requiring a second-line treatment, but eventually the viremia cleared. No patients experienced CMV disease. Fungal infections were documented in five (16%) patients, comprising invasive fungal infections in two cases and mucosal fungal infections in three. Four patients died of transplant-related causes, and three of these died before day + 100. Infection was considered the primary cause of death in one patient (pulmonary aspergillosis) and contributed to death in another two. The actuarial probability of nonrelapse mortality at 100 days was 10% (95% confidence interval, 3-26%). Our preliminary results suggest that NST is associated to a low incidence of bacteremia or fungal and viral infections. Whether these findings would translate into an improved overall survival needs to be confirmed in larger prospective studies.

KW - Bacteremia

KW - Fungal infections

KW - Hematopoietic stem cell transplantation

KW - Infectious complications

KW - Viral infections

UR - http://www.scopus.com/inward/record.url?scp=0242291869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242291869&partnerID=8YFLogxK

U2 - 10.1034/j.1399-3062.2003.00027.x

DO - 10.1034/j.1399-3062.2003.00027.x

M3 - Article

C2 - 14617301

AN - SCOPUS:0242291869

VL - 5

SP - 132

EP - 139

JO - Transplant Infectious Disease

JF - Transplant Infectious Disease

SN - 1398-2273

IS - 3

ER -